We’re excited to share that DefiniGEN will be at the Society of Toxicology (SOT) Annual Meeting, presenting two posters showcasing our cutting-edge iPSC-derived hepatocyte technology:
📝 Poster 1: iPSC-derived hepatocytes demonstrate functional Phase I and Phase II drug metabolism and accurately predict drug-induced liver injury (DILI), offering a novel model for large-scale predictive toxicity and hepatic safety studies.
📝 Poster 2: In vitro liver disease models using iPSC-derived hepatocytes show altered Phase I gene expression profiles compared to wild-type cells.
Come visit us at Booth #704 to learn how our iPSC-derived liver models are transforming drug safety and disease research. Let’s connect, collaborate, and advance toxicology together!